Insights into CSF-1R Expression in the Tumor Microenvironment

The colony-stimulating factor 1 receptor (CSF-1R) plays a pivotal role in orchestrating cellular interactions within the tumor microenvironment (TME). Although the CSF-1R has been extensively studied in myeloid cells, the expression of this receptor and its emerging role in other cell types in the T...

Full description

Bibliographic Details
Published in:	Biomedicines
Main Authors:	Caterina Tomassetti, Gaia Insinga, Francesca Gimigliano, Andrea Morrione, Antonio Giordano, Emanuele Giurisato
Format:	Article
Language:	English
Published:	MDPI AG 2024-10-01
Subjects:	CSF-1R tumor microenvironment CAFs ECs TAMs MDSCs
Online Access:	https://www.mdpi.com/2227-9059/12/10/2381

Similar Items

Targeting the CSF1/CSF1R signaling pathway: an innovative strategy for ultrasound combined with macrophage exhaustion in pancreatic cancer therapy
by: Qian Wang, et al.
Published: (2024-10-01)

Tumor microenvironment in primary central nervous system lymphoma (PCNSL)
by: Qiqi Jin, et al.
Published: (2024-12-01)

Modulating tumor-associated macrophages through CSF1R inhibition: a potential therapeutic strategy for HNSCC
by: Kaiting Chen, et al.
Published: (2025-01-01)

Decreased melanoma CSF-1 secretion by Cannabigerol treatment reprograms regulatory myeloid cells and reduces tumor progression
by: Iris Wyrobnik, et al.
Published: (2023-12-01)

Insights into CSF-1/CSF-1R signaling: the role of macrophage in radiotherapy
by: Qingchao Shang, et al.
Published: (2025-02-01)

Potentiating vascular-targeted photodynamic therapy through CSF-1R modulation of myeloid cells in a preclinical model of prostate cancer
by: Souhil Lebdai, et al.
Published: (2019-06-01)

Targeting M-MDSCs enhances the therapeutic effect of BNCT in the 4-NQO-induced murine head and neck squamous cell carcinoma model
by: Chun-Hsiang Chang, et al.
Published: (2023-10-01)

Study on the mechanism of MDSC-platelets and their role in the breast cancer microenvironment
by: Xinpu Han, et al.
Published: (2024-02-01)

CSF1R is a Prognostic Biomarker and Correlated with Immune Cell Infiltration in the Gastric Cancer Microenvironment
by: Chen D, et al.
Published: (2021-04-01)

HMGB1 Signaling-Mediated Tumor Immunity in Cancer Progress
by: Jinlin Wen, et al.
Published: (2023-10-01)

Significance of Immunosuppressive Cells as a Target for Immunotherapies in Melanoma and Non-Melanoma Skin Cancers
by: Taku Fujimura, et al.
Published: (2020-07-01)

Nutritional Exchanges Within Tumor Microenvironment: Impact for Cancer Aggressiveness
by: Giuseppina Comito, et al.
Published: (2020-03-01)

Pharmacologic inhibition of CSF-1R suppresses intrinsic tumor cell growth in osteosarcoma with CSF-1R overexpression
by: Cheng Dai, et al.
Published: (2025-08-01)

The cancer-associated fibroblast-related signature predicts prognosis and indicates immune microenvironment infiltration in gastric cancer
by: Tsz Kin Mak, et al.
Published: (2022-07-01)

Uncovering common transcriptional features shared by mature peripheral blood PMN-MDSCs and tumor-infiltrating neutrophils in humans
by: Chiara Lattanzi, et al.
Published: (2025-12-01)

SQLE-mediated squalene metabolism promotes tumor immune evasion in pancreatic cancer
by: Junchen Pan, et al.
Published: (2024-12-01)

CSF-1R: A promising therapeutic target for various diseases
by: Chen-Yueh Wen, et al.
Published: (2024-06-01)

Cancer-associated fibroblasts: The chief architect in the tumor microenvironment
by: Mrinmoy Sarkar, et al.
Published: (2023-01-01)

Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials
by: Hao Zhang, et al.
Published: (2023-10-01)

Cancer Stem Cells and the Tumor Microenvironment in Gastric Cancer
by: Ying Yang, et al.
Published: (2022-01-01)

Gas6/TAM Signalling Negatively Regulates Inflammatory Induction of GM-CSF in Mouse Brain Microglia
by: Shannon E. Gilchrist, et al.
Published: (2021-11-01)

The Dark Side of Fibroblasts: Cancer-Associated Fibroblasts as Mediators of Immunosuppression in the Tumor Microenvironment
by: Lea Monteran, et al.
Published: (2019-08-01)

Preclinical evaluation of 3D185, a novel potent inhibitor of FGFR1/2/3 and CSF-1R, in FGFR-dependent and macrophage-dominant cancer models
by: Xia Peng, et al.
Published: (2019-08-01)

Slit2/Robo1 signaling inhibits small‐cell lung cancer by targeting β‐catenin signaling in tumor cells and macrophages
by: Dinesh K. Ahirwar, et al.
Published: (2023-05-01)

Editorial: Crosstalk between cancer-associated fibroblasts and tumor cells in the tumor microenvironment: an emerging target of anti-cancer immunotherapy
by: Chunxue Zhang, et al.
Published: (2023-08-01)

Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy
by: Michael A. Cannarile, et al.
Published: (2017-07-01)

Triggering Receptor Expressed on Myeloid Cells-2 (TREM2) Interacts With Colony-Stimulating Factor 1 Receptor (CSF1R) but Is Not Necessary for CSF1/CSF1R-Mediated Microglial Survival
by: Baoying Cheng, et al.
Published: (2021-03-01)

GM-CSF enhanced the effect of CHOP and R-CHOP on inhibiting diffuse large B-cell lymphoma progression via influencing the macrophage polarization
by: Yu Zhang, et al.
Published: (2021-03-01)

Bridging the tumor microenvironment: the pivotal role of cancer-associated fibroblasts in tumor cachexia development
by: Guoming Chen, et al.
Published: (2025-07-01)

Increased expression of CSF1 in patients with eosinophilic asthma
by: Lijuan Du, et al.
Published: (2023-05-01)

Research progress on the mechanisms of CSF3R mutations in leukemogenesis and treatment strategies
by: Ningxuan Wang, et al.
Published: (2025-08-01)

Calpain 2 regulates IL-1α secretion and inhibits tumor development via modulating calpain 1 expression in the tumor microenvironment
by: Zuhairah Binte Hanafi, et al.
Published: (2025-12-01)

Metabolic Rewiring in the Tumor Microenvironment to Support Immunotherapy: A Focus on Neutrophils, Polymorphonuclear Myeloid-Derived Suppressor Cells and Natural Killer Cells
by: Andrea De Lerma Barbaro, et al.
Published: (2021-10-01)

Targeting CSF1R in myeloid-derived suppressor cells: insights into its immunomodulatory functions in colorectal cancer and therapeutic implications
by: Xin Tong, et al.
Published: (2024-07-01)

Inter-Tumor Heterogeneity—Melanomas Respond Differently to GM-CSF-Mediated Activation
by: Adi Moshe, et al.
Published: (2020-07-01)

PPP1R15A-expressing monocytic MDSCs promote immunosuppressive liver microenvironment in fibrosis-associated hepatocellular carcinoma
by: Xiaoyu Liu, et al.
Published: (2024-07-01)

Homozygous mutation in CSF1R causes brain abnormalities, neurodegeneration, and dysosteosclerosis (BANDDOS)
by: Hossein Daghagh, et al.
Published: (2023-05-01)

Development and validation of cancer-associated fibroblasts-related gene landscape in prognosis and immune microenvironment of bladder cancer
by: Meng Zhang, et al.
Published: (2023-06-01)

Attenuated CSF‐1R signalling drives cerebrovascular pathology
by: Conor Delaney, et al.
Published: (2020-12-01)

Co-Delivery Nanomicelles for Potentiating TNBC Immunotherapy by Synergetically Reshaping CAFs-Mediated Tumor Stroma and Reprogramming Immunosuppressive Microenvironment
by: Zhang Y, et al.
Published: (2023-07-01)